M E Chamberland

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Emerging infectious disease issues in blood safety
    M E Chamberland
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:552-3. 2001
  2. pmc Blood safety
    M E Chamberland
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 4:410-1. 1998
  3. pmc Risk and management of blood-borne infections in health care workers
    E M Beltrami
    HIV Infections Branch, Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U S Department of Health and Human Services, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 13:385-407. 2000
  4. ncbi request reprint Simian foamy virus infection in a blood donor
    R S Boneva
    Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Transfusion 42:886-91. 2002
  5. ncbi request reprint Rapid evaluation of risk of white particulate matter in blood components by a statewide survey of transfusion reactions
    M Iwamoto
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Atlanta, GA, USA
    Transfusion 44:967-72. 2004
  6. ncbi request reprint The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion
    S H Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 45:1073-83. 2005

Collaborators

Detail Information

Publications6

  1. pmc Emerging infectious disease issues in blood safety
    M E Chamberland
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Emerg Infect Dis 7:552-3. 2001
    ..Several newly discovered hepatitis viruses and agents of transmissible spongiform encephalopathies present unique challenges in assessing possible risks they may pose to the safety of blood and plasma products...
  2. pmc Blood safety
    M E Chamberland
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 4:410-1. 1998
    ..Finally, vigilance needs to extend to the developing world, where the basic elements to reduce transfusion-transmitted infections and systems of disease surveillance are often not available...
  3. pmc Risk and management of blood-borne infections in health care workers
    E M Beltrami
    HIV Infections Branch, Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U S Department of Health and Human Services, Atlanta, Georgia 30333, USA
    Clin Microbiol Rev 13:385-407. 2000
    ..A sustained commitment to the occupational health of all HCWs will ensure maximum protection for HCWs and patients and the availability of optimal medical care for all who need it...
  4. ncbi request reprint Simian foamy virus infection in a blood donor
    R S Boneva
    Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Transfusion 42:886-91. 2002
    ..Human-to-human transmission of SFV through transfusion and its pathogenicity have not been studied...
  5. ncbi request reprint Rapid evaluation of risk of white particulate matter in blood components by a statewide survey of transfusion reactions
    M Iwamoto
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Atlanta, GA, USA
    Transfusion 44:967-72. 2004
    ..To investigate possible adverse patient events associated with WPM, transfusion reaction rates were examined...
  6. ncbi request reprint The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion
    S H Kleinman
    Westat, Rockville, Maryland, USA
    Transfusion 45:1073-83. 2005
    ..An ongoing issue in transfusion medicine is whether newly identified or emerging pathogens can be transmitted by transfusion. One method to study this question is through the use of a contemporary linked donor-recipient repository...